Physician profile
Katrina King
NPI 1245901693
$43,862.96
in general payments reported to CMS, 2019-2025
12 companies · $272 in 2025
The $272 reported for 2025 was more than what a typical Nurse Practitioner provider received nationally (typical 2025 total: $174).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2022: $17.13 · 2023: $13.00 · 2024: $44K · 2025: $272.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Debt Forgiveness: $43K · Food and Beverage: $616.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Debt Forgiveness | $43,229.78 |
| Food and Beverage | $616.05 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Angiodynamics, INC. | $43,265.26 | 2024 | Auryon Atherectomy Catheter 1.5 Mm Otw, Auryon Atherectomy Catheter 2.0 Mm Otw, Auryon Laser System 100-120 Vac |
| Viiv Healthcare Company | $122.48 | 2025 | |
| Tactile Systems Technology INC | $88.36 | 2024-2025 | Flexitouch Plus, Entre Plus, Nimbl |
| Bard Peripheral Vascular, INC. | $86.04 | 2025 | Venovo |
| Boston Scientific Corporation | $78.04 | 2024-2025 | Varithena Administration Pack |
| Janssen Pharmaceuticals, INC | $69.38 | 2024 | Xarelto |
| Novartis Pharmaceuticals Corporation | $32.70 | 2024 | |
| Becton, Dickinson and Company | $31.58 | 2024 | Venclose Maven Catheter |
| Abbvie INC. | $30.13 | 2022-2023 | |
| Cordis US Corp. | $22.40 | 2024 | Rain Sheath |
| Novo Nordisk INC | $20.55 | 2024 | Ozempic |
| Cashflow Solutions, LLC | $16.04 | 2024 | Lympha Press Optimal Plus(US) Bt, Pcd-52 737a (US) White, Pcd-51 731a (US) - White |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Katrina King listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.